Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer

• Linda Bosserman ,

  * E-mail: bestchemo@gmail.com

  Current address: City of Hope Medical Group, Duarte, CA, United States of America

  Affiliation Wilshire Oncology Medical Group-US Oncology, La Verne, CA, United States of America

  ⨯
• Karl Rogers,

  Affiliation Nashville Oncology Associates, Nashville, TN, United States of America

  ⨯
• Carl Willis,

  Affiliation Nashville Oncology Associates, Nashville, TN, United States of America

  ⨯
• Dirk Davidson,

  Affiliation Tennessee Plateau Oncology, Crossville, TN, United States of America

  ⨯
• Pat Whitworth,

  Affiliation Nashville Breast Center, Nashville, TN, United States of America

  ⨯
• Misagh Karimi,

  Affiliation Wilshire Oncology Medical Group-US Oncology, La Verne, CA, United States of America

  ⨯
• Gargi Upadhyaya,

  Affiliation Wilshire Oncology Medical Group-US Oncology, La Verne, CA, United States of America

  ⨯
• James Rutledge,

  Affiliation Data Vision, Dayton OH, United States of America

  ⨯
• Allan Hallquist,

  Affiliation DiaTech Oncology, Montreal, Canada and Nashville, TN, United States of America

  ⨯
• Mathieu Perree,

  Affiliation DiaTech Oncology, Montreal, Canada and Nashville, TN, United States of America

  ⨯
• Cary A. Presant

  Affiliations Wilshire Oncology Medical Group-US Oncology, La Verne, CA, United States of America, DiaTech Oncology, Montreal, Canada and Nashville, TN, United States of America

  ⨯